PLASMA NATRIURETIC PEPTIDES LEVELS AND ECHOCARDIOGRAPHIC FINDINGS IN LATE SUBCLINICAL ANTHRACYCLINE TOXICITY

被引:4
作者
Kantar, Mehmet [1 ]
Levent, Erturk [1 ]
Cetingul, Nazan [1 ]
Ulger, Zulal [1 ]
Ozyurek, Ruhi [1 ]
Aksoylar, Serap [1 ]
Kansoy, Savas [1 ]
机构
[1] Ege Univ, Sch Med, Dept Pediat, Pediat Oncol & Transplantat Unit, Izmir, Turkey
关键词
anthracycline; cardiac toxicity; children; natriuretic peptides; echocardiography;
D O I
10.1080/08880010802435393
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to evaluate late cardiac toxicity by comprehensive echocardiographic study, and to determine whether plasma atrial natriuretic peptide and brain natriuretic peptide levels might be indicators of neurohumoral activation. The study included 49 long-term survivors and 21 controls. A wide variety of echocardiographic parameters were measured or calculated. Plasma peptide levels were determined. Patients had significant changes in different echocardiographic parameters that are suggestive of LV systolic and diastolic dysfunction. Plasma peptide levels were not increased. The authors have found significant subclinic cardiotoxicity by echocardiography. Survivors seem to have normal plasma natriuretic peptide levels in long-term period.
引用
收藏
页码:723 / 733
页数:11
相关论文
共 46 条
[41]  
2-W
[42]  
TurnerGomes SO, 1996, MED PEDIATR ONCOL, V26, P160, DOI 10.1002/(SICI)1096-911X(199603)26:3<160::AID-MPO3>3.0.CO
[43]  
2-I
[44]   Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging - A pilot study [J].
Wassmuth, R ;
Lentzsch, S ;
Erdbruegger, U ;
Schulz-Menger, J ;
Doerken, B ;
Dietz, R ;
Friedrich, MG .
AMERICAN HEART JOURNAL, 2001, 141 (06) :1007-1013
[45]   Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin [J].
Wexler, LH ;
Andrich, MP ;
Venzon, D ;
Berg, SL ;
WeaverMcClure, L ;
Chen, CC ;
Dilsizian, V ;
Avila, N ;
Jarosinski, P ;
Balis, FM ;
Poplack, DG ;
Horowitz, ME .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :362-372
[46]   FUNCTIONAL MYOCARDIAL IMPAIRMENT IN CHILDREN TREATED WITH ANTHRACYCLINES FOR CANCER [J].
YEUNG, ST ;
YOONG, C ;
SPINK, J ;
GALBRAITH, A ;
SMITH, PJ .
LANCET, 1991, 337 (8745) :816-818